Verastem, Inc. short interest in 2024
In 2024, Verastem, Inc.'s disclosed short interest ran from 1.74% of shares outstanding on 12 Jan 2024 to 6.94% on 31 Dec 2024, a change of +5.20 percentage points. The year's high was 8.96% on 15 Jul 2024 and its low 1.74% on 12 Jan 2024, averaging 4.67% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.94 days on 30 Apr 2024. Full history: Verastem, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 1.74% (12 Jan 2024)
- End of year
- 6.94% (31 Dec 2024)
- Change
- +5.20 pp
- High
- 8.96% (15 Jul 2024)
- Low
- 1.74% (12 Jan 2024)
- Average
- 4.67%
- Highest days to cover
- 10.94 (30 Apr 2024)
- SEC filings marked
- 4
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 1.74% | 4.49 | |
| 31 Jan 2024 | 2.12% | 4.34 | |
| 15 Feb 2024 | 2.89% | 4.21 | |
| 29 Feb 2024 | 3.02% | 4.95 | |
| 15 Mar 2024 | 3.06% | 5.15 | 10-K filed |
| 28 Mar 2024 | 2.51% | 3.32 | |
| 15 Apr 2024 | 3.19% | 8.06 | |
| 30 Apr 2024 | 3.26% | 10.94 | |
| 15 May 2024 | 3.20% | 6.71 | 10-Q filed |
| 14 Jun 2024 | 5.21% | 1.84 | |
| 28 Jun 2024 | 5.05% | 1.31 | |
| 15 Jul 2024 | 8.96% | 3.83 | |
| 31 Jul 2024 | 7.28% | 2.32 | |
| 15 Aug 2024 | 4.89% | 3.77 | 10-Q filed |
| 30 Aug 2024 | 5.21% | 4.90 | |
| 13 Sep 2024 | 5.12% | 4.69 | |
| 30 Sep 2024 | 5.84% | 3.65 | |
| 15 Oct 2024 | 6.06% | 4.47 | |
| 31 Oct 2024 | 6.12% | 1.67 | |
| 15 Nov 2024 | 5.30% | 2.19 | 10-Q filed |
| 29 Nov 2024 | 4.50% | 1.99 | |
| 13 Dec 2024 | 5.89% | 2.47 | |
| 31 Dec 2024 | 6.94% | 1.29 |
See also: Verastem, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.